Robotic walking suit may awaken the brain after severe injury

NCT ID NCT07709559

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study explores whether walking with an overground robotic exoskeleton can increase behavioral responsiveness and brain activity in adults with disorders of consciousness after a severe brain injury. Participants, aged 18 to 70 and in a coma, unresponsive wakefulness syndrome, or minimally conscious state, will complete six sessions over two weeks that may include lying down, sitting, standing, and walking with the device. Researchers will measure responsiveness using the Coma Recovery Scale-Revised and brain activity with EEG to see if upright walking offers unique benefits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
overground robotic exoskeleton (ORE) device
What this could lead to
If walking with a robotic exoskeleton boosts responsiveness, it could point toward a new therapy to help people with disorders of consciousness regain awareness.
What could go wrong
This is a very small, early-stage study with only 18 participants, so results may not apply to everyone. The intervention is also complex and may not be safe or tolerable for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DISORDERS OF CONSCIOUSNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Consciousness Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Spaulding Rehabilitation Hospital

    Boston, Massachusetts, 02129, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.